URGN Historical Earnings image   This URGN historical earnings page last updated 11/19/2021
URGN Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202111/15/20210.01B
Q2 20218/4/20210.01B
Q1 20215/13/20210.01B
Q4 20203/18/20210.01B
Q3 202011/9/20200.00B
Q2 20208/10/20200.00B
Q1 20205/7/2020NA
Q4 20193/2/2020NA
Q3 201911/12/2019NA
Q2 20198/9/20190.02M
Q1 20195/9/2019NA
Q4 20182/28/2019NA
Q3 201811/12/2018283000
Q2 20188/14/2018364000
Q1 20185/15/2018481000
Q4 20173/15/2018327000
Q3 201711/14/20177.81M
Q2 20178/14/2017NA
URGN Historical Earnings EPS
Data adjusted for URGN split history

PeriodHistorical Earnings DateGAAP
Q3 202111/15/2021-1.350
Q2 20218/4/2021-1.170
Q1 20215/13/2021-1.170
Q4 20203/18/2021-1.380
Q3 202011/9/2020-1.310
Q2 20208/10/2020-1.440
Q1 20205/7/2020-1.790
Q4 20193/2/2020-1.860
Q3 201911/12/2019-1.060
Q2 20198/9/2019-1.080
Q1 20195/9/2019-1.110
Q4 20182/28/2019-1.46
Q3 201811/12/2018-1.28
Q2 20188/14/2018-1.14
Q1 20185/15/2018-0.88
Q4 20173/15/2018-0.74
Q3 201711/14/2017-0.02
Q2 20178/14/2017-0.7
What was the record high URGN historical earnings result?
In terms of earnings or revenue, what is the best URGN historical earnings result that UroGen Pharma has ever posted, and when?

✔️Accepted answer: Within our data set, the highest URGN historical earnings result was set in Q3 2017, when UroGen Pharma posted results of -0.02/share. The most successful revenue quarter within our data set was Q2 2021 when UroGen Pharma reported revenue of 0.01B.

What was the lowest UroGen Pharma historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest URGN has reported, and when?

✔️Accepted answer: Within our data set, the lowest URGN historical earnings result was set in Q4 2019, when UroGen Pharma posted results of -1.860/share. The smallest revenue quarter within our data set was Q1 2020 when UroGen Pharma reported revenue of NA.

On this page we presented the URGN historical earnings date information for UroGen Pharma. Reviewing that URGN Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2017, when URGN posted gaap of -0.02/share. Meanwhile the lowest URGN historical earnings result was in Q4 2019, when URGN posted gaap of -1.860/share. Moving to UroGen Pharmas historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2021 when URGN reported 0.01B in revenue, while the smallest revenue quarter was Q1 2020 when URGN reported NA in revenue.

For self directed investors doing their due diligence on URGN or any other given stock, their research can benefit from looking into all of the UroGen Pharma historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into UroGen Pharma historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for URGN. Thanks for visiting, and the next time you need to research URGN historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.
 

URGN Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.